European industry puts up strong fight with regulators over implants
This article was originally published in Clinica
The EU medical devices industry has built a strong case to oppose any proposals for fundamental changes to the EU Medical Devices Directive during its current five-year review. It is very worried about proposals that have been put forward by some EU competent authorities, which could have far-reaching consequences for manufacturers, particularly those concerning the reclassification of most implants from Class IIb to Class III.
You may also be interested in...
Abbott is launching a second test to detect COVID-19. The diagnostics giant announced on 27 March the release of a rapid, point-of-care test that can deliver results within five minutes.
President Trump on 27 March finally pulled the trigger on using his powers under the Defense Production Act, forcing General Motors Co. to manufacture medical ventilators. The only thing is, GM is already doing that.
Theradaptive's “paint-like” regenerative therapeutic can be applied to any device to promote bone regrowth or regenerate tissue.